We next tested the following hypotheses: (i) inhibition of CaMKII should disrupt the wound leading edge in prostate cancer cell lines (ii) activation of Wnt5A signaling in 1542-NPTX cells should promote actin remodeling of the wound as observed in 1542-CP3TX cells. This evidence concerns the gene CAMK2G and prostate carcinoma.